Fludarabine, Cyclophosphamide, and Alemtuzumab in Treating Patients With Recurrent or Metastatic Renal Cell Carcinoma (Kidney Cancer) Undergoing Allogeneic Stem Cell Transplantation
Clinical trial NCT00073879 · COMPLETED
Trial details
- NCT number
- NCT00073879
- Sponsor
- Baylor College of Medicine
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Primary completion
- 2004-04-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.